Dr. Reddy's to Release Q2 FY06 Results on October 29, 2005; Earnings Call Slated for October 31, 2.30 PM IST/4.00 AM EST

Summary of Events
Event Date and Time (IST) Medium
----------------------------------------------------------------------
Release of financial October 29, after the Email, Media, Company
results Board Meeting website, Businesswire

Earnings Call October 31, 2.30 PM Hosted by the Company
IST / 4.00 AM EST (Details below)

Webcast of Earnings October 31, 2.30 PM URL available on
Call IST / 4.00 AM EST Company's website,
through January 29, 2006 www.drreddys.com

Transcripts of the Within 10 working days URL available on
Earnings call of the Call Company's website,
www.drreddys.com

Earnings Call

Following the release, the management of the Company will host anearnings call to discuss the Company's financial performance.
Date Timing Dial-in number
----------------------------------------------------------------------
October 31, 2005 India - 2.30 PM Participants from India
US EST - 4.00 AM 022.2781.2277
Stand by - 022.5591.7977

Participants from the US
1-706-643-0243
Conference ID: 1634660

Participants outside India & US
(Singtel bridge)
65-66687509
Conference Code: 926524#
----------------------------------------------------------------------

No password/pin number is necessary to dial in to any of the othercalls. As participation in the call is limited, early registration isencouraged. The operator will provide instructions on asking questionsbefore and during the call.

Audio Webcast

The audio webcast of the earnings call will be available to allinterested parties at www.drreddys.com. Please visit the web site atleast fifteen minutes ahead of the scheduled start time to registerand to download and install any necessary audio software. Participantsin the webcast can listen to the proceedings, but will not be able toask questions. The replay will be available 2 hours after the earningscall, through January 29, 2006.

Transcript

The transcript of the earnings call will also be available on theCompany's website within 10 workings days of the call.

About Dr Reddy's

Established in 1984, Dr. Reddy's Laboratories (NYSE:RDY) is anemerging global pharmaceutical company with proven basic researchcapabilities. The company develops, manufactures and markets a widerange of pharmaceutical products in India and overseas. Dr. Reddy'sproduces finished dosage forms, active pharmaceutical ingredients,diagnostic kits, critical care and biotechnology products. The basicresearch program of Dr. Reddy's focuses on cancer, diabetes, bacterialinfections and pain management. Website: http://www.drreddys.com

Safe Harbor

This press release includes forward-looking statements, as definedin the U.S. Private Securities Litigation Reform Act of 1995. We havebased these forward-looking statements on our current expectations andprojections about future events. Such statements involve known andunknown risks, uncertainties and other factors that may cause actualresults to differ materially. Such factors include, but are notlimited to, changes in local and global economic conditions, ourability to successfully implement our strategy, the market acceptanceof and demand for our products, our growth and expansion,technological change and our exposure to market risks. By theirnature, these expectations and projections are only estimates andcould be materially different from actual results in the future.